Klor-con M Tablet, Extended Release
Product Images NDC 55154-5634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Klor-con M (NDC 55154-5634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (Ee3a1815 7325 4838 9764 Fe1db68877b6 00)

Bag Label (Ee3a1815 7325 4838 9764 Fe1db68877b6 00)
This is a prescription medication called Klor-Con M20, which consists of extended-release tablets containing potassium chloride. Each tablet has 20 milliequivalents (mEq) of potassium. The tablets use micro-dispersible technology to extend the release of the active ingredient. Dosage must be personalized for each patient, and package storage follows specific temperature requirements. This is not a child-resistant package and should be kept out of reach of children. Klor-Con and Micro-Dispersible Technology are registered trademarks of Upsher-Smith Laboratories, LLC. The medication is manufactured in Maple Grove, MN, and distributed by Cardinal Health in Dublin, OH.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.